1. Anand, S, Dagenais, G, Mohan, V, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the epidream cohort study. Eur J Prev. Cardiol 2012; 19: 755–764.
Google Scholar | SAGE Journals | ISI2. Rawshani, A, Rawshani, A, Franzén, S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017; 376: 1407–1418.
Google Scholar | Crossref | Medline | ISI3. Tancredi, M, Rosengren, A, Svensson, A-M, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 2015; 373: 1720–1732.
Google Scholar | Crossref | Medline | ISI4. Fowkes, FGR, Rudan, D, Rudan, I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340.
Google Scholar | Crossref | Medline | ISI5. Althouse, AD, Abbott, JD, Forker, AD, et al. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 diabetes (bari 2d) trial. Diabetes Care 2014; 37: 1346–1352.
Google Scholar | Crossref | Medline | ISI6. Mohammedi, K, Woodward, M, Hirakawa, Y, et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care 2016; 39: 1796–1803.
Google Scholar | Crossref | Medline7. Malyar, NM, Freisinger, E, Meyborg, M, et al. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diabetes Complicat 2016; 30: 1117–1122.
Google Scholar | Crossref | Medline8. Vrsalovic, M, Vucur, K, Vrsalovic Presecki, A, Fabijanic, D, Milosevic, M. Impact of diabetes on mortality in peripheral artery disease: a meta-analysis. Clin Cardiol 2017; 40: 287–291.
Google Scholar | Crossref | Medline9. Humphries, MD, Brunson, A, Hedayati, N, Romano, P, Melnkow, J. amputation risk in patients with diabetes mellitus and peripheral artery disease using statewide data. Ann Vasc Surg 2016; 30: 123–131.
Google Scholar | Crossref | Medline10. Agnelli, G, Belch, JJF, Baumgartner, I, Giovas, P, Hoffmann, U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis 2020; 293: 94–100.
Google Scholar | Crossref | Medline11. Aboyans, V, Ricco, JB, Bartelink, MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the european society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J 2017; 39: 763–816.
Google Scholar | Crossref12. Low Wang, CC, Blomster, JI, Heizer, G, et al. Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease. J Am Coll Cardiol 2018; 72: 3274–3284.
Google Scholar | Crossref | Medline13. Cambou, JP, Aboyans, V, Constans, J, Lacroix, P, Dentans, C, Bura, A. Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry. Eur J Vasc Endovasc Surg 2010; 39: 577–585.
Google Scholar | Crossref | Medline | ISI14. Gerhard-Herman, MD, Gornik, HL, Barrett, C, et al. AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Circulation 2016; 135: e686.
Google Scholar | Medline15. Frank, U, Nikol, S, Belch, J, et al. ESVM guideline on peripheral arterial disease. VASA. zeitschrift fur gefasskrankheiten 2019; 48(Suppl 102): 1–79.
Google Scholar16. Conte, MS, Conte, MS, Pomposelli, FB, et al. Society for Vascular Surgery Lower Extremity Guidelines Writing Group . Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 2015; 61(3 Suppl l): 2S–41S.
Google Scholar | Crossref | Medline17. Lapébie, F-X, Bura-Rivière, A, Lacroix, P, et al. Impact of angiotensin receptor blockers on mortality after hospitalization for symptomatic lower extremity artery disease. Eur Heart J Cardiovasc Pharmacother 2020 Apr 9: pvaa026. Doi: 10.1093/ehjcvp/pvaa026.
Google Scholar | Crossref | Medline18. Coudene, A, Lapébie, F-X, Desormais, I, et al. evolution of major amputation risk in patients hospitalized in france for critical limb ischemia: the COPART registry. Angiology 2021; 72: 315–321.
Google Scholar | SAGE Journals19. Alberti, KGMM, Eckel, RH, Grundy, SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009; 120: 1640–1645.
Google Scholar | Crossref | Medline | ISI20. Conte, MS, Bradbury, AW, Kolh, P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69(6S): 3S–e40.
Google Scholar | Crossref | Medline21. Levey, AS, Stevens, LA, Schmid, CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.
Google Scholar | Crossref | Medline | ISI22. Levey, AS, Eckardt, K-U, Dorman, NM, et al. Nomenclature for kidney function and disease: executive summary and glossary from a kidney disease: improving global outcomes consensus conference. Transplantation 2020; 104: 1986–1994.
Google Scholar | Crossref | Medline23. Caro, J, Migliaccio-Walle, K, Ishak, KJ, Proskorovsky, I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005; 5: 14.
Google Scholar | Crossref | Medline24. Mueller, T, Hinterreiter, F, Luft, C, Poelz, W, Haltmayer, M, Dieplinger, B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 2014; 59: 1291–1299.
Google Scholar | Crossref | Medline | ISI25. Abu Dabrh, AM, Steffen, MW, Undavalli, C, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 2015; 62: 1642–1651.
Google Scholar | Crossref | Medline | ISI26. Reinecke, H, Unrath, M, Freisinger, E, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 2015; 36: 932–938.
Google Scholar | Crossref | Medline | ISI27. Beckman, JA, Creager, MA, Libby, P. Diabetes and atherosclerosis. J Am Med Assoc 2002; 287: 2570–2581.
Google Scholar | Crossref | Medline | ISI28. Golledge, J, Quigley, F, Velu, R, Walker, PJ, Moxon, JV. Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovasc Diabetol 2014; 13: 147.
Google Scholar | Crossref | Medline29. Anand, SS, Caron, F, Eikelboom, JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 2018; 71: 2306–2315.
Google Scholar | Crossref | Medline30. Sigvant, B, Hasvold, P, Kragsterman, B, et al. Cardivascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: results from a Swedish nationwide study. J Vasc Surg 2017; 66: 507–514.
Google Scholar | Crossref | Medline31. Kennedy-Martin, T, Curtis, S, Faries, D, Robinson, S, Johnston, J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015; 16: 495.
Google Scholar | Crossref | Medline32. Paraskevas, KI, de Borst, GJ, Veith, FJ. Why randomized controlled trials do not always reflect reality. J Vasc Surg 2019; 70: 607–614.
Google Scholar | Crossref | Medline33. Sigvant, B, Lundin, F, Wahlberg, E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 2016; 51: 395–403.
Google Scholar | Crossref | Medline | ISI34. Sartipy, F, Sigvant, B, Lundin, F, Wahlberg, E. Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome. Eur J Vasc Endovasc Surg 2018; 55: 529–536.
Google Scholar | Crossref | Medline35. Visonà, A, De Paoli, A, Fedeli, U, et al. Abnormal ankle-brachial index (ABI) predicts primary and secondary cardiovascular risk and cancer mortality. Eur J Intern Med 2020; 77: 79–85.
Google Scholar | Crossref | Medline36. Fiotti, N, Altamura, N, Cappelli, C, Schillan, M, Guarnieri, G, Giansante, C. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. Eur J Vasc Endovasc Surg 2003; 26: 374–380.
Google Scholar | Crossref | Medline | ISI37. Rantner, B, Kollerits, B, Pohlhammer, J, et al. The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study. Sci Rep 2017; 7: 45833.
Google Scholar | Crossref38. Koene, RJ, Prizment, AE, Blaes, A, Konety, SH. Shared risk factors in cardiovascular disease and cancer. Circulation 2016; 133: 1104–1114.
Google Scholar | Crossref | Medline39. Raghavan, S, Vassy, JL, Ho, YL, et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc 2019; 8: e011295.
Google Scholar | Crossref | Medline40. Aboyans, V, Criqui, MH, Denenberg, JO, Knoke, JD, Ridker, PM, Fronek, A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623–2629.
Google Scholar | Crossref | Medline | ISI41. Ferraresi, R, Mauri, G, Losurdo, F, et al. BAD transmission and SAD distribution: a new scenario for critical limb ischemia. J Cardiovasc Surg 2018; 59: 655–664.
Google Scholar | Crossref | Medline42. Ahmad, J . The diabetic foot. Diabetes & Metabolic Syndrome: Clin Res Rev 2016; 10: 48–60.
Google Scholar | Crossref | Medline | ISI43. Spreen, MI, Gremmels, H, Teraa, M, et al. Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials. Diabetes Care 2016; 39: 2058–2064.
Google Scholar | Crossref | Medline44. Lee, H-F, Chen, S-W, Liu, J-R, et al. Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor. Cardiovasc Diabetol 2020; 19: 160.
Google Scholar | Crossref | Medline45. Bonaca, MP, Bauersachs, RM, Anand, SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 2020; 382: 1994–2004.
Google Scholar | Crossref | Medline46. Kaplovitch, E, Eikelboom, JW, Dyal, L, et al.